학술논문
A randomized study comparing short-time infusion of oxaliplatin in combination with capecitabine XELOX(30) and chronomodulated XELOX(30) as first-line therapy in patients with advanced colorectal cancer
Document Type
Artikel
Author
Source
Annals of oncology : official journal of the European Society for Medical Oncology. 21(1):87-91
Subject
Language
English
English
English
ISSN
1569-8041